Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MOLINA HEALTHCARE, INC.

(MOH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 7 2518 50812 61216 016--
Entreprise Value (EV)1 4 2025 3658 7109 9027 3394 741
P/E ratio 11,0x11,8x18,9x22,4x17,7x15,6x
Yield ------
Capitalization / Revenue 0,38x0,51x0,65x0,61x0,58x0,55x
EV / Revenue 0,22x0,32x0,45x0,38x0,27x0,16x
EV / EBITDA 3,42x4,67x6,55x8,14x5,04x2,93x
Price to Book 4,38x4,29x5,99x6,23x3,38x2,50x
Nbr of stocks (in thousands) 62 38962 70059 30058 400--
Reference price (USD) 116136213274274274
Announcement Date 02/11/201902/10/202002/10/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 18 89016 82919 42326 38727 61929 372
EBITDA1 1 2301 1481 3301 2171 4571 620
Operating profit (EBIT)1 1 1311 0441 2421 0901 3391 471
Operating Margin 5,99%6,20%6,39%4,13%4,85%5,01%
Pre-Tax Profit (EBT)1 9999729619521 2191 360
Net income1 707737673710881996
Net margin 3,74%4,38%3,46%2,69%3,19%3,39%
EPS2 10,611,511,212,215,517,5
Dividend per Share2 ------
Announcement Date 02/11/201902/10/202002/10/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1
Net sales1 5 2356 5226 8006 5816 6147 171
EBITDA1 390398310270251421
Operating profit (EBIT)1 366365279235229394
Operating Margin 6,98%5,60%4,10%3,57%3,46%5,49%
Pre-Tax Profit (EBT)1 51,0305243212202357
Net income1 34,0228185155139266
Net margin 0,65%3,50%2,72%2,35%2,10%3,71%
EPS2 0,563,893,162,642,424,61
Dividend per Share ------
Announcement Date 02/10/202104/28/202107/28/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 3 0493 1433 9026 1148 67811 275
Leverage (Debt / EBITDA) -2,48x-2,74x-2,93x-5,02x-5,96x-6,96x
Free Cash Flow1 -3443701 8161 2251 1091 156
ROE (Net Profit / Equities) 47,4%40,9%33,2%30,0%26,8%22,7%
Shareholders' equity1 1 4921 8032 0282 3673 2844 394
ROA (Net Profit / Asset) 9,05%10,6%8,25%8,30%8,60%8,40%
Assets1 7 8136 9718 1598 55710 24211 854
Book Value Per Share2 26,631,635,544,081,2110
Cash Flow per Share2 -4,716,65-22,120,420,5
Capex1 30,057,074,065,085,789,4
Capex / Sales 0,16%0,34%0,38%0,25%0,31%0,30%
Announcement Date 02/11/201902/10/202002/10/2021---
1 USD in Million
2 USD
Key data
Capitalization (USD) 16 016 200 000
Net sales (USD) 19 423 000 000
Number of employees 10 500
Sales / Employee (USD) 1 849 810
Free-Float 99,1%
Free-Float capitalization (USD) 15 876 675 038
Avg. Exchange 20 sessions (USD) 76 191 518
Average Daily Capital Traded 0,48%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA